InvestorsHub Logo
Followers 7
Posts 410
Boards Moderated 0
Alias Born 06/04/2014

Re: None

Monday, 02/20/2017 8:52:27 AM

Monday, February 20, 2017 8:52:27 AM

Post# of 21531
This is an insightful comment from the discussion over at Seeking Alpha:

Lawdawg05

You need to keep in mind that the people participating in this trial have moderate-severe or severe Alzheimer's disease. Their guardians have made the decision for them to participate in this trial, and the patients most likely have no idea that they are even involved in a trial. My point is that there will be no placebo effect. The professionals administering this trial know this, so if there are signs of efficacy, the professionals have reason to believe the patients are receiving bryostatin. The families likely appreciate this too.

http://seekingalpha.com/article/4046795-neurotrope-bioscience-upcoming-alzheimers-trial-results-may-propel-share-price

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News